Literature DB >> 9081624

Ex vivo gene transfer of brain-derived neurotrophic factor to the intact rat forebrain: neurotrophic effects on cholinergic neurons.

A Martinez-Serrano1, P A Hantzopoulos, A Björklund.   

Abstract

Neurotrophic effects of human brain-derived neurotrophic factor (hBDNF) on forebrain cholinergic neurons were addressed after ex vivo gene transfer to the intact adult rat brain, using a conditionally immortalized neural progenitor cell line (CINP) engineered to secrete the neurotrophin (2.8 ng/h/10(6) cells). This cell line was derived by repeated retroviral infection of the parental neural precursor line HiB5 followed by subcloning. The cells survived well in the host brain for long periods of time (up to 4 weeks), and induced a hypertrophic response of cholinergic neurons (positive for acetylcholinesterase, choline acetyltransferase or low-affinity nerve growth factor receptor) in the nucleus basalis magnocellularis and striatum. We conclude that these cholinergic cell groups are responsive to a low-level supply (nanograms per day) of BDNF in vivo when the neurotrophin is administered locally in the vicinity of the cell bodies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9081624     DOI: 10.1111/j.1460-9568.1996.tb01258.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  10 in total

1.  Long-term functional recovery from age-induced spatial memory impairments by nerve growth factor gene transfer to the rat basal forebrain.

Authors:  A Martínez-Serrano; W Fischer; S Söderström; T Ebendal; A Björklund
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

2.  A transgenic mouse model engineered to investigate human brain-derived neurotrophic factor in vivo.

Authors:  Fabrice Guillemot; Italina Cerutti; Charles Auffray; Marie-Dominique Devignes
Journal:  Transgenic Res       Date:  2007-01-16       Impact factor: 2.788

Review 3.  Cell-mediated drug delivery.

Authors:  Elena V Batrakova; Howard E Gendelman; Alexander V Kabanov
Journal:  Expert Opin Drug Deliv       Date:  2011-02-24       Impact factor: 6.648

4.  Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells.

Authors:  A Martínez-Serrano; A Björklund
Journal:  J Neurosci       Date:  1996-08-01       Impact factor: 6.167

5.  Cell delivery of therapeutic nanoparticles.

Authors:  JoEllyn McMillan; Elena Batrakova; Howard E Gendelman
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

6.  Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseases.

Authors:  Matthew J Haney; Yuling Zhao; Emily B Harrison; Vivek Mahajan; Shaheen Ahmed; Zhijian He; Poornima Suresh; Shawn D Hingtgen; Natalia L Klyachko; R Lee Mosley; Howard E Gendelman; Alexander V Kabanov; Elena V Batrakova
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

7.  Thalamostriatal degeneration contributes to dystonia and cholinergic interneuron dysfunction in a mouse model of Huntington's disease.

Authors:  Gabriel Crevier-Sorbo; Vladimir V Rymar; Raphael Crevier-Sorbo; Abbas F Sadikot
Journal:  Acta Neuropathol Commun       Date:  2020-02-07       Impact factor: 7.801

8.  GDNF-transfected macrophages produce potent neuroprotective effects in Parkinson's disease mouse model.

Authors:  Yuling Zhao; Matthew J Haney; Richa Gupta; John P Bohnsack; Zhijian He; Alexander V Kabanov; Elena V Batrakova
Journal:  PLoS One       Date:  2014-09-17       Impact factor: 3.240

9.  Genetically modified macrophages accomplish targeted gene delivery to the inflamed brain in transgenic Parkin Q311X(A) mice: importance of administration routes.

Authors:  Matthew J Haney; Yuling Zhao; James Fay; Hwang Duhyeong; Mengzhe Wang; Hui Wang; Zibo Li; Yueh Z Lee; Mohan K Karuppan; Nazira El-Hage; Alexander V Kabanov; Elena V Batrakova
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

Review 10.  Stem cell therapy for Alzheimer's disease.

Authors:  Xin-Yu Liu; Lin-Po Yang; Lan Zhao
Journal:  World J Stem Cells       Date:  2020-08-26       Impact factor: 5.326

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.